AKT1 and breast cancer: Furthermore, this metabolite inhibits the PI3K/AKT pathway in MCF-7 breast cancer cells by reducing the expression of proteins such as p-PI3K, PI3K, AKT, and p-AKT, thereby limiting their proliferation [32].